Nuvalent, Inc. share price logo

Nuvalent, Inc. Share Price

NASDAQ: NUVL

Small Cap

$78.28

-1.09

(-1.37%)

as on

Nuvalent, Inc. Stock Performance

as on September 17, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $78.09
    $80.67
    downward going graph

    0.24%

    Downside

    3.05%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $55.54
    $113.51
    downward going graph

    29.06%

    Downside

    45.01%

    Upside

    downward going graph

Nuvalent, Inc. share price movements today

Previous Close
$79.37
Open
$79.31
Volume
198.8K
Day's Low - High
$78.09 - $80.67
52 Week Low - High
$55.54 - $113.51

Nuvalent, Inc. Historical Returns

1 Month Return
+ 5.83 %
3 Month Return
+ 5.44 %
1 Year Return
-28.26 %
3 Year Return
+ 355.15 %
5 Year Return
0 %

Nuvalent, Inc. Stock Fundamentals & Key Indicators

Check Nuvalent, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.8B

EPS (TTM)

-5.0863

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

2359400.00%

Nuvalent, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Nuvalent, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Nuvalent, Inc. image
Nuvalent, Inc.
BUY$5.8BNANA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$61.1B251.26%-505.15-12.96%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$38.7BNANA-3.89%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$101.2B47.46%28.0931.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$59.6B0.6%14.131.37%

Stock Returns calculator for Nuvalent, Inc. Stock including INR - Dollar returns

The Nuvalent, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Nuvalent, Inc. investment value today

Current value as on today

₹74,654

Returns

₹25,346

(-25.35%)

Returns from Nuvalent, Inc. Stock

₹30,213 (-30.21%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Nuvalent, Inc. Stock

Based on 16 analysts

BUY

93.75%

Buy

6.25%

Hold

0.00%

Sell

Based on 16 analysts, 93.75% of analysts recommend a 'BUY' rating for Nuvalent, Inc.. Average target price of $117.33

Nuvalent, Inc. Share Price Target

Get share price movements and forecasts by analysts on Nuvalent, Inc..

What analysts predicted

33.28%UPSIDE

Target Price

$117.33

Current Price

$78.28

Analyzed by

16 Analysts

Target

$117.33

Nuvalent, Inc. target price $117.33, a slight upside of 33.28% compared to current price of $78.28. According to 16 analysts rating.

Nuvalent, Inc. Stock's Interest Amongst Investors

Search interest for Nuvalent, Inc. Stock has increased by 44% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:44% versus previous 30 day period

Nuvalent, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-30
-34
-38
-46
-52
-65
-76
-86
-94
-104
EBITDA
-30
-34
-38
-46
-52
-65
-76
-86
-94
-104
Interest Expense
5
4
5
18
8
8
8
-
11
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-25
-29
-33
-38
-44
-56
-84
-74
-84
-99
Income Tax Expense
-5
0
0
5
0
0
0
0
0
0
Net Income
-25
-29
-33
-38
-44
-57
-84
-74
-84
-99
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Nuvalent, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
Operating Income
-10
-16
-45
-86
-149
-280
EBITDA
-11
-14
-46
-77
-126
-280
Interest Expense
-
-
0
4
23
38
Depreciation
-
-
-
-
-
-
Income Before Tax
-11
-14
-46
-81
-126
-259
Income Tax Expense
1
-2
0
-8
0
0
Net Income
-11
-14
-46
-73
-126
-260
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Nuvalent, Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-29
-33
-38
-44
-57
-84
-74
-84
-99
Operating Cash Flow
-22
-22
-30
-36
-41
-45
-62
-54
-76
Investing Cash Flow
1
38
-56
-206
16
-212
-170
25
77
Financing Cash Flow
1
2
333
5
4
550
8
4
5
Change in Cash
-19
17
246
-236
-20
291
-223
-24
6

Nuvalent, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-14
-46
-81
-126
-260
Operating Cash Flow
-14
-40
-64
-99
-185
Investing Cash Flow
-220
-220
-10
-143
-573
Financing Cash Flow
22
318
248
336
568
Change in Cash
7
58
173
93
-189

Global Institutional Holdings in Nuvalent, Inc.

Funds
Holdings
Deerfield Management Co
24.95%
FMR Inc
13.78%
Paradigm Biocapital Advisors LP
7.31%
Vanguard Group Inc
6.16%
BlackRock Inc
5.2%
See all

Insights on Nuvalent, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, NUVL stock has moved up by 348.9%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, NUVL has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 68.2% return, outperforming this stock by 92.4%

About Nuvalent, Inc.

nuvalent is improving human health by developing breakthrough small molecule therapeutics that engage biological targets in new ways using cutting-edge chemical insights. by expanding the universe of targets that interact with small molecules, we are generating therapeutics with activities not previously possible, including modulation of ‘undruggable’ targets. our unique approach is leading to first-in-class and best-in-class small molecule therapeutics that will significantly impact patient’s lives.
OrganisationNuvalent, Inc.
HeadquartersOne Broadway, Cambridge, MA, United States, 02142
IndustryServices
CEODr. James R. Porter Ph.D.
E-voting on sharesClick here to vote

Key Management of Nuvalent, Inc.

Name

Title

Ms. Deborah Ann Miller J.D., Ph.D.

Chief Legal Officer & Secretary

Dr. Henry Pelish Ph.D.

Chief Scientific Officer

Ms. Darlene Noci

Chief Development Officer

Dr. Christopher D. Turner M.D.

Chief Medical Officer

Dr. Benjamin Lane Ph.D.

Senior Vice President of Technical Operations

Mr. Matthew Metivier M.B.A.

Senior Vice President of Human Resources

Mr. John Soglia Ph.D.

Senior Vice President of Translational Development

Dr. James R. Porter Ph.D.

CEO, President & Director

Prof. Matthew D. Shair Ph.D.

Founder, Head of Scientific Advisory Board & Director

Ms. Alexandra Balcom CPA, M.B.A.

CFO & Treasurer

FAQs

What is Nuvalent, Inc. share price today?

Nuvalent, Inc. share price today is $78.28 as on at the close of the market. Nuvalent, Inc. share today touched a day high of $80.67 and a low of $78.09.

What is the 52 week high and 52 week low for Nuvalent, Inc. share?

Nuvalent, Inc. share touched a 52 week high of $113.51 on and a 52 week low of $55.54 on . Nuvalent, Inc. stock price today i.e. is closed at $78.28,which is 31.04% down from its 52 week high and 40.96% up from its 52 week low.

What is Nuvalent, Inc.'s market capitalisation today?

Nuvalent, Inc. market capitalisation is $0.01T as on .

How to invest in Nuvalent, Inc. Stock (NUVL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Nuvalent, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Nuvalent, Inc. Shares that will get you 0.0192 shares as per Nuvalent, Inc. share price of $78.28 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Nuvalent, Inc. Stock (NUVL) from India?

Indian investors can start investing in Nuvalent, Inc. (NUVL) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Nuvalent, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Nuvalent, Inc. share’s latest price of $78.28 as on September 17, 2025 at 1:29 am IST, you will get 0.1277 shares of Nuvalent, Inc.. Learn more about fractional shares .